Recent studies of our team have found that the upregulated expressions of various plasma inflammatory factors, such as IL-1β, IL-12, and TNF-α, in patients with MMD suggested that inflammation might regulate the process of MMD (31). This evidence concerns the gene IL1B and multiminicore myopathy.